Teva Pharmaceuticals

GPTKB entity

Statements (59)
Predicate Object
gptkbp:instanceOf gptkb:biotechnology
gptkbp:acquiredBy gptkb:Cephalon
gptkb:Actavis_Generics
gptkb:Barr_Pharmaceuticals
gptkbp:annualReport https://www.tevapharm.com/investors/reports/
gptkbp:businessModel multinational
gptkbp:CEO gptkb:Richard_Francis
gptkbp:chairman gptkb:Amir_Elstein
gptkbp:country gptkb:Israel
gptkbp:founded gptkb:Salomon,_Levin,_and_Elstein_Ltd.
1901
gptkbp:founder gptkb:Yitschak_Levin
gptkb:Chaim_Salomon
gptkb:Moshe_Levin
gptkbp:headquarters_location gptkb:Petah_Tikva
https://www.w3.org/2000/01/rdf-schema#label Teva Pharmaceuticals
gptkbp:industry pharmaceuticals
gptkbp:ISIN US8816242098
gptkbp:legalForm gptkb:public_company
gptkbp:listedOn gptkb:TA-125_Index
gptkb:TA-35_Index
gptkb:Forbes_Global_2000
gptkb:S&P_500_Index
gptkbp:logo Teva Pharmaceuticals logo.svg
gptkbp:market world's largest generic drug manufacturer
gptkbp:member gptkb:Pharmaceutical_Research_and_Manufacturers_of_America
gptkbp:mergedInto gptkb:Assia
gptkb:Zori
gptkbp:netIncome $-2.35 billion (2022)
gptkbp:notable_executive gptkb:Eli_Hurvitz_(former_CEO)
Erez Vigodman (former CEO)
Kåre Schultz (former CEO)
Shlomo Yanai (former CEO)
gptkbp:notable_legal_issue gptkb:opioid_litigation_in_the_United_States
price-fixing allegations
gptkbp:notableProduct gptkb:Ajovy
gptkb:Austedo
gptkb:Copaxone
gptkbp:numberOfEmployees ~37,000
gptkbp:parentCompany gptkb:Teva_Pharmaceutical_Industries_Ltd.
gptkbp:products generic drugs
over-the-counter drugs
specialty medicines
gptkbp:revenue $15.8 billion (2022)
gptkbp:servesArea worldwide
gptkbp:stockExchange gptkb:New_York_Stock_Exchange
gptkb:Tel_Aviv_Stock_Exchange
gptkbp:stockSymbol gptkb:TEVA
gptkbp:subsidiary gptkb:Teva_USA
gptkb:Teva_Canada_Limited
gptkb:Teva_UK_Limited
gptkbp:website https://www.tevapharm.com/
gptkbp:bfsParent gptkb:Adderall
gptkb:The_Pill
gptkb:Chemi_Peres
gptkb:Ajovy
gptkb:Austedo
gptkb:Copaxone
gptkbp:bfsLayer 6